A pharmacist checklist for direct oral anticoagulant management: Raising the bar

Abstract

Get full access to this article

View all access options for this article.

References

Hart

Pearce

Aguilar

. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146(12):857-67.

Macle

Cairns

Leblanc

et al . 2016 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol 2016;32(10):1170-85.

Kearon

Akl

Ornelas

et al . Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149(2):315-52.

Weitz

Semchuk

Turpie

AGG

et al . Trends in prescribing oral anticoagulants in Canada, 2008-2014. Clin Ther 2015;37(11):2506-14.

Shore

Carey

Turakhi

Jackevicius

. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the Veterans Health Administration. Am Heart J 2014;167(6):810-7.

Tsuyuki

Rosenthal

Pearson

. A randomized trial of a community-based approach to dyslipidemia management: pharmacist prescribing to achieve cholesterol targets (RxACT Study). Can Pharm J (Ott) 2016;149:283-92.

Shore

Lanbert-Kerzner

et al . Site-level variation in and practices associated with dabigatran adherence. JAMA 2015;313(14):1443-50.

Ashjian

Kurtz

Renner

et al . Evaluation of a pharmacist-let outpatient direct oral anticoagulant service. Am J Health Sys Pharm 2017;74(7)483-9.

Papastergiou

De Rango

Wang

et al . Canadian pharmacist needs assessment in the management of anticoagulation therapy: results of the International Pharmacists for Anticoagulation Care Taskforce (iPACT) survey. Int J Clin Pharm. In press.

10.

Gladstone

Geerts

Douketis

et al . How to monitor patients receiving direct oral anticoagulants for stroke prevention in atrial fibrillation: a practice tool endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network and the Canadian Cardiovascular Society. Ann Intern Med 2015;163(5):382-5.

11.

Direct Oral Anticoagulation Monitoring Checklist for Pharmacists. Available: http://thrombosiscanada.ca/wp-content/uploads/2016/03/DOAC-Checklist-formatted-v20.pdf (accessed Jan. 10, 2018).

12.

Ewen

Rettig-Ewen

Mahfoud

et al . Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol 2014;103:173-82.

13.

Gladstone

Bui

Fang

et al . Potentially preventable stroke in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009;40(1):235-40.

14.

Fang

Chang

et al . Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007;120(8):700-5.

15.

Dans

Connolly

Wallentin

Yang

. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation 2013;127:634-40.

16.

Ruff

Giugliano

Murphy

. Concomitant use of single antiplatelet therapy with edoxoban or warfarin in patients with atrial fibrillation: analysis from the ENGAGE AF-TIMI 48 trial. J Am Heart Assoc 2016;5(2):e002587.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.04 MB